Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 23;16(2):171.
doi: 10.3390/ph16020171.

A Focused Review on Cognitive Improvement by the Genus Salvia L. (Sage)-From Ethnopharmacology to Clinical Evidence

Affiliations
Review

A Focused Review on Cognitive Improvement by the Genus Salvia L. (Sage)-From Ethnopharmacology to Clinical Evidence

Abdulselam Ertas et al. Pharmaceuticals (Basel). .

Abstract

Ethnopharmacology has been an important starting point in medical and pharmaceutical sciences for discovering drug candidates from natural sources. In this regard, the genus Salvia L., commonly known as sage, is one of the best-known medicinal and aromatic plants of the Lamiaceae family; it has been recorded as being used for memory enhancement in European folk medicine. Despite the various uses of sage in folk medicines, the records that have pointed out sage's memory-enhancing properties have paved the way for the aforementioned effect to be proven on scientific grounds. There are many preclinical studies and excellent reviews referring to the favorable effect of different species of sage against the cognitive dysfunction that is related to Alzheimer's disease (AD). Hence, the current review discusses clinical studies that provide evidence for the effect of Salvia species on cognitive dysfunction. Clinical studies have shown that some Salvia species, i.e., hydroalcoholic extracts and essential oils of S. officinalis L. and S. lavandulaefolia leaves in particular, have been the most prominently effective species in patients with mild to moderate AD, and these species have shown positive effects on the memory of young and healthy people. However, the numbers of subjects in the studies were small, and standardized extracts were not used for the most part. Our review points out to the need for longer-term clinical studies with higher numbers of subjects being administered standardized sage preparations.

Keywords: Alzheimer’s disease; Salvia; clinical study; cognitive dysfunction; ethnopharmacology; memory enhancement; sage.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Salvia officinalis L. (Lamiaceae) (Photo taken by Ilkay Erdogan Orhan).
Figure 2
Figure 2
Promising compounds detected in or isolated from Salvia species against AD.
Figure 2
Figure 2
Promising compounds detected in or isolated from Salvia species against AD.

References

    1. Machado S., Cunha M., Minc D., Portella C.E., Velasques B., Basile L.F., Cagy M., Piedade R., Ribeiro P. Alzheimer’s disease and implicit memory. Arq. Neuropsiquiatr. 2009;67:334–342. doi: 10.1590/S0004-282X2009000200034. - DOI - PubMed
    1. Jahn H. Memory loss in Alzheimer’s disease. Dialogues Clin. Neurosci. 2013;15:445–454. doi: 10.31887/DCNS.2013.15.4/hjahn. - DOI - PMC - PubMed
    1. Zokaei N., Husain M. Processes of Visuospatial Attention and Working Memory. Volume 41. Springer; Cham, Switzerland: 2019. Working memory in Alzheimer’s disease and Parkinson’s disease; pp. 325–344. - DOI - PubMed
    1. Park J.H., Lee S.A. The fragility of temporal memory in Alzheimer’s disease. J. Alzheimers Dis. 2021;79:1631–1646. doi: 10.3233/JAD-200892. - DOI - PubMed
    1. Peña-Casanova J., Sanchez-Benavides G., de Sola S., Manero-Borrás R.M., Casals-Coll M. Neuropsychology of Alzheimer’s disease. Arch. Med. Res. 2012;43:686–693. doi: 10.1016/j.arcmed.2012.08.015. - DOI - PubMed

LinkOut - more resources